JPRN-UMIN000013056已完成1 期
chemotherapy for soft tissue sarcoma - chemotherapy for soft tissue sarcoma
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 40 人开始时间: 2014年2月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •WBC<3000/ul Neutrophil <1500/ul Plt<75000/ul Hb < 7g/ul CCr< 60ml/min AST/ALT > 75IU/l(male),67.5IU/l(female) T-Bil > 3.0mg/dl No documented consent EF<50% allergy for planned drugs
研究者
相似试验
招募中
不适用
Evaluation of soft-tissue sarcoma therapy response during neoadjuvant radiotherapy through quantification of free circulating tumor DNA (ctDNA) and multiparametric MRI (mpMRI)C49Malignant neoplasm of other connective and soft tissueDRKS00027479niversitätsklinikum Freiburg30
已完成
不适用
chemotherapy for primary bone sarcoma over 41 except for Ewing sarcomaprimary bone sarcomaJPRN-UMIN000023089Gifu Gfraduate University school of medicine200
Unknown
1 期
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue SarcomaSoft Tissue SarcomaNCT00541840Grupo Espanol de Investigacion en Sarcomas24
已完成
1 期
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue SarcomaAdvanced Soft Tissue SarcomaNCT01684449Grupo Espanol de Investigacion en Sarcomas28
已完成
2 期
Chidamide Combined With Toripalimab in SarcomaSarcomaNCT04025931Sun Yat-sen University73